Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19K Sell
3
-6
-67% -$1.71K ﹤0.01% 550
2026
Q1
$1.56K Hold
9
﹤0.01% 535
2025
Q4
$2.31K Buy
9
+3
+50% +$786 ﹤0.01% 501
2025
Q3
$1.56K Buy
+6
New +$1.58K ﹤0.01% 618
2025
Q2
Sell
-8
Closed -$2.12K 638
2025
Q1
$2.12K Hold
8
﹤0.01% 445
2024
Q4
$2.03K Sell
8
-10
-56% -$2.68K ﹤0.01% 473
2024
Q3
$5.7K Hold
18
﹤0.01% 347
2024
Q2
$6.73K Hold
18
﹤0.01% 314
2024
Q1
$6.24K Sell
18
-2
-10% -$758 ﹤0.01% 327
2023
Q4
$9.16K Buy
+20
New +$9.86K 0.01% 266

Other funds holding HUM

Aspect Partners's HUM Position: Q2 2026 in Review

Aspect Partners reduced its Humana (HUM) stake by 67% in Q2 2026, selling an estimated $1.71K and leaving 3 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #550.

Aspect Partners first reported a position in HUM in Q4 2023 and has held it in 10 quarters since. The position peaked at $9.16K in Q4 2023. 180 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Aspect Partners held 3 shares of Humana worth $1.19K as of Q2 2026.
  • Aspect Partners sold 6 Humana shares in Q2 2026, an estimated $1.71K.
  • Humana made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #550 holding.
  • Aspect Partners first reported a position in Humana in Q4 2023 and has held it in 10 quarters since.
  • Aspect Partners's Humana position peaked at $9.16K in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.